Encompass Health Corporation vs Eli Lilly & Co.
EHC vs LLY — side-by-side comparison from reported financials. EHC leads 3, LLY leads 8 of 11 comparable metrics.
Encompass Health Corporation
EHC · Healthcare
$123.33+0.64%Strained
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | EHC | LLY |
|---|---|---|
| Price | $123.33 | $1 177.20 |
| Market cap | $12.2B | $1.05T |
| Revenue (TTM) | $6.21B | $79.7B |
| Revenue growth | +10.9% | +31.7% |
| Net margin | 10.0% | 33.5% |
| Free cash flow | $413M | $18.2B |
| Net cash (debt) | ($2.42B) | ($35.2B) |
| 1-year price return | +0.1% | +37.6% |
| P/E | 19.6 | 41.6 |
| P/E vs own history (cheap-side %) | 60% | 88% |
| Dividend yield | 0.62% | 0.52% |
| Return on equity | 25% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 29,944 | 50,000 |
Full résumé-style profiles: EHC CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.